Leishmaniosis in Dogs: Understanding the Rising Threat and Our Response
The Increasing Prevalence of Canine Leishmaniosis
Canine leishmaniosis, a parasitic disease transmitted by phlebotomine sand flies, is on the rise. Climate change plays a pivotal role in the expansion of these sandy vectors, concentrated mainly in southern Europe but increasingly posing a threat in northern areas. This escalation poses significant challenges for both veterinary medicine and public health due to its zoonotic potential, making it a critical issue to be aware of.
Current Statistics and Impact
In Spain alone, an estimated 385,000 dogs are infected annually. However, this figure may not reflect the true scale, as many dogs do not show symptoms. As highlighted by Leti Pharma, canine leishmaniosis impacts not only veterinary medicine but also human health as an emerging zoonosis. This dual threat emphasizes the need for a proactive approach in tackling the disease.
Veterinarians: The Frontline of Defense
As professionals, veterinarians play a crucial role in communicating the risks of leishmaniosis to pet owners. According to Leti Pharma, education and sensitization are key. By providing accurate information and encouraging preventive measures, veterinarians can act today to safeguard their clients’ pets and families tomorrow. The Let’s Stop Leishmaniosis, Let’s Defend campaign by Leti Pharma focuses on raising awareness and promoting vaccination as a critical tool against this disease.
LetiFend: The Future of Vaccination
LetiFend, the first and only authorized vaccine in Europe against canine leishmaniosis, is a vital step in reducing the disease’s impact. Introduced in 2017, this vaccine uses a chimeric protein derivative of Leishmania infantum, obtained through recombinant DNA technology, providing robust protection. Integrating LetiFend into the Annual Vaccination Protocol for dogs in endemic areas, combined with external repellents, offers the highest level of protection.
Leti Pharma’s Commitment to One Health
Advocating for a One Health strategy, Leti Pharma is dedicated to enhancing the protection of pets and thus contributing to the health of families. By engaging with veterinarians and providing detailed materials and training tools, they are combating leishmaniosis on multiple fronts.
Iberzoo Prospect: A Collaborative Approach
Leti Pharma invites veterinary professionals to their stand at the upcoming Iberzoo Ppet, emphasizing the significance of collective efforts. Located at stand 10E16, they will host formative activities to further educate practitioners and encourage involvement in the Let’s Stop Leishmaniosis, Let’s Defend movement.
Table: Key Facts on LetiFend
| Aspect | Details |
|---|---|
| Market Introduction | 2017 |
| Geographical Coverage | Most endemic European countries |
| Active Ingredient | Chimeric protein derivative of Leishmania infantum |
| Technology | Recombinant DNA |
| Maximum Protection | Combination of vaccination and external repellents |
Pro Tips
Did you know? Combining LetiFend with external flea and tick repellents can significantly reduce the risk of disease transmission. Always consult with your vet before changing vaccination protocols!
Raising awareness and adopting preventive measures, like vaccination and proper use of repellent products, are our best defenses against the growing threat of canine leishmaniosis. The stakes are high, but with coordinated efforts and informed pet owners, we can safeguard the health of our furry friends and our families.
Let’s Stop Leishmaniosis, Let’s Defend.
FAQ Section
What is canine leishmaniosis?
Canine leishmaniosis is a parasitic disease transmitted by phlebotomine sand flies, primarily affecting dogs. It can also pose a threat to human health as an emerging zoonosis.
How can vaccination help?
Vaccination, specifically with LetiFend, is a proven method to prevent the development of canine leishmaniosis or mitigate its severity. Incorporating it into the annual vaccination protocol in endemic areas is crucial.
What role do veterinarians play?
Veterinarians act as the bridge between scientific information and pet owners. Educating owners about the risks and prevention measures is a key role.
How effective is LetiFend?
LetiFend, authorized in Europe, has shown to be an effective tool when combined with external repellents.
This article aims to bring clarity to the growing threat of canine leishmaniosis and promote proactive measures to combat it. For all veterinarians and pet owners, knowing the risks and solutions can ensure a healthier future for our pets and families. Don’t forget to share your experiences and stay informed through Leti Pharma’s resources. Together, we can stop the spread of leishmaniosis.
